IRONWOOD PHARMACEUTICALS INCIRWDEarnings & Financial Report
Nasdaq
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
NextMar 31, 2026
IRWD Q3 2025 Key Financial Metrics
Revenue
$122.1M
Gross Profit
N/A
Operating Profit
$75.5M
Net Profit
$40.1M
Gross Margin
N/A
Operating Margin
61.8%
Net Margin
32.8%
YoY Growth
33.3%
EPS
$0.23
Financial Flow
IRONWOOD PHARMACEUTICALS INC Q3 2025 Financial Summary
IRONWOOD PHARMACEUTICALS INC reported revenue of $122.1M for Q3 2025, with a net profit of $40.1M (32.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $122.1M |
|---|---|
| Net Profit | $40.1M |
| Gross Margin | N/A |
| Operating Margin | 61.8% |
| Report Period | Q3 2025 |
IRONWOOD PHARMACEUTICALS INC Annual Revenue by Year
IRONWOOD PHARMACEUTICALS INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $351.4M).
| Year | Annual Revenue |
|---|---|
| 2024 | $351.4M |
| 2023 | $442.7M |
| 2022 | $410.6M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $117.6M | $74.9M | $94.4M | $91.6M | $90.5M | $41.1M | $85.2M | $122.1M |
| YoY Growth | 9.7% | -28.0% | -12.1% | -19.5% | -23.0% | -45.1% | -9.7% | 33.3% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $471.1M | $438.8M | $395.6M | $389.5M | $350.9M | $327.2M | $342.9M | $396.1M |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $-346.3M | $-330.5M | $-321.7M | $-311.3M | $-301.3M | $-334.1M | $-308.2M | $-264.2M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $35.8M | $45.0M | $33.5M | $9.9M | $15.2M | $20.0M | $-15.1M | $47.6M |